Clinical Trial Update: Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the impact of metformin on gut microbiota and glycemic control in newly diagnosed type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED